CD44 and prostate carcinoma: Aberrantly upregulated in multiple carcinomas, like breast cancer [32], lung adenocarcinoma [33], colorectal cancer [34], prostate cancer [35], and RCC [36], CD44 takes part in various physiological processes including tumorigenesis and cancer progression [37].